HemOnc & COVID-19 Session with Amer Zeidan, John Mascarenhas, Jan Bewersdorf & Rory Shallis

VJHEMONC
7/28/20, 3:00 PM
America/Argentina/Buenos_Aires GMT-3

Description

In this session, Amer Zeidan, John Mascarenhas, Jan Bewersdorf & Rory Shallis will discuss and debate the special considerations for managing patients with hematological malignancies in the COVID-19 era.

 

The topics for discussion include the recommendations made in a recent publication they co-authored in Lancet Haematology:

• Reducing nosocomial COVID-19 infections and resource allocation

• Clinical trial participation

• Treating patients with ALL, CML, MPNs, MDS and AML

 

This session will be made available on-demand on VJHemOnc.com after the event to all those who have registered.

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Inglês

 

Speakers

Amer Zeidan, John Mascarenhas, Jan Bewersdorf, Rory Shallis

 

Link to the Event

Banner to the Event

HemOnc & COVID-19 Session with Amer Zeidan, John Mascarenhas, Jan Bewersdorf & Rory Shallis